Stay updated on PDR001/MBG453 w/ Decitabine in AML Clinical Trial
Sign up to get notified when there's something new on the PDR001/MBG453 w/ Decitabine in AML Clinical Trial page.

Latest updates to the PDR001/MBG453 w/ Decitabine in AML Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedThe page’s footer “Revision” value is updated from v3.5.2 to v3.5.3, indicating a site/version release rather than a change to the clinical trial record itself.SummaryDifference0.0%

- Check21 days agoChange DetectedRevision: v3.5.2.SummaryDifference0.0%

- Check29 days agoNo Change Detected
- Check51 days agoChange DetectedRevision log updated to add v3.5.0 and remove v3.4.3.SummaryDifference0.0%

- Check58 days agoChange DetectedRevision: v3.4.3 is now shown, replacing the previous v3.4.2.SummaryDifference0.0%

- Check86 days agoChange DetectedA new Revision: v3.4.2 is shown, and the prior Revision: v3.4.1 notice is removed. The changes appear to be site-wide UI/notice updates rather than updates to the study details.SummaryDifference0.3%

- Check93 days agoChange DetectedA site-wide notice about a lapse in government funding and the NIH Clinical Center's operating status was added, and the page revision updated from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

Stay in the know with updates to PDR001/MBG453 w/ Decitabine in AML Clinical Trial
Enter your email address, and we'll notify you when there's something new on the PDR001/MBG453 w/ Decitabine in AML Clinical Trial page.